Transplant CE Activities

Incorporating New Therapies to Hone the Treatment of Resistant or Refractory CMV in the Post-SOT Setting: Proceedings from a Clinical Olympics^℠

1.0 CE Credit(s)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

0.75 CE Credit(s)

Taking Stock of the Evolving Treatment Landscape for Acute GvHD in HSCT: Proceedings from a Clinical Olympics℠

1.00 CE Credit(s)

Assessing Potential Implications of New Data on CMV Treatment in Transplant Recipients

0.5 CE Credit(s)

RMEI DECISION SUPPORT AIDS

Refractory & Resistant Cytomegalovirus (CMV) in Solid Organ Transplant: Decision Support Aid

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Transplant
Decision Support Aid

RMEI Presentations

Multi-Year Analysis of Transplant Education 2016-2018

LATEST TRANSPLANT ARTICLES

Latest Transplant Articles

Obstructive Hypertrophic Cardiomyopathy August 6, 2026
A 31-year-old man was evaluated for an abnormal ECG. Echocardiography revealed marked ventricular hypertrophy. Subsequent imaging (shown in a video) showed near-complete apposition of the ventricular walls during systole.
Julian-Kai Nishizono, Marohito Nakata
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation July 30, 2026
A patient with high-level HLA sensitization received T-cell engager–mediated HLA antibody depletion with teclistamab, a bispecific B-cell maturation antigen–directed CD3 T-cell engager, which enabled kidney transplantation.
Martina Schatzl, Katharina A. Mayer, Hermine Agis, Susanne Haindl, Daniela Kriks, Gottfried Fischer, Markus Exner, Gideon Hönger, Nikolina Veljancic, Daniela M. Allmer, Irene Graf, Matthias Diebold, Philip F. Halloran, Anne Halpin, Caishun Li, Lori West, Nicolas Kozakowski, Georg A. Böhmig
Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain July 30, 2026
The selective NaV1.8 inhibitor LTG-001 led to significantly greater reductions in pain scores than placebo over the course of 48 hours among patients who had moderate or severe pain after abdominoplasty.
Neil Singla, Nathaniel P. Katz, Ben Vaughn, Timothy Rogier, Todd Bertoch, Harold Minkowitz, Mallory Loflin

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021

Previously Published CE Activities

Incorporating New Therapies to Hone the Treatment of Resistant or Refractory CMV in the Post-SOT Setting: Proceedings from a Clinical Olympics^℠

1.0 CE Credit(s)